Holen Sie sich die Stockscreener-App
4.21
0.00%
0.00
Handel nachbörslich:
4.18
-0.03
-0.71%
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN
Is Organogenesis Holdings Inc. (2PQ) stock protected from inflationJuly 2025 Action & Free Technical Pattern Based Buy Signals - ulpravda.ru
Is Organogenesis Holdings Inc. stock a buy in volatile markets2025 Top Decliners & Growth Oriented Trade Recommendations - ulpravda.ru
What margin trends mean for Organogenesis Holdings Inc. stockIPO Watch & Pattern Based Trade Signal System - ulpravda.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
Three rising investors just landed bigger roles at a healthcare PE firm - Stock Titan
Organogenesis (NASDAQ:ORGO) Trading Down 5% – Time to Sell? - Defense World
Organogenesis (NASDAQ:ORGO) Shares Down 5%Here's What Happened - MarketBeat
Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia
Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com
Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks
Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat
Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision By Investing.com - Investing.com South Africa
Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria
Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa
Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria
Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com
Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative
Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan
Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn
Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets
BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN
Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: 47% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Is Organogenesis Holdings Inc. stock dividend yield sustainableJuly 2025 Outlook & Breakout Confirmation Trade Signals - DonanımHaber
Is Organogenesis Holdings Inc. stock supported by strong cash flows2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Organogenesis (NASDAQ:ORGO) Director Glenn Nussdorf Sells 200,000 Shares - MarketBeat
Organogenesis Holdings Insider Sold Shares Worth $1,027,060, According to a Recent SEC Filing - marketscreener.com
Organogenesis Holdings Inc. (ORGO) director sells 200,000 shares - Stock Titan
How Organogenesis Holdings Inc. stock benefits from global expansion2025 Big Picture & Low Risk High Win Rate Stock Picks - Улправда
Organogenesis (NASDAQ:ORGO) Trading Up 8.5%Here's What Happened - MarketBeat
How Organogenesis Holdings Inc. stock reacts to oil pricesBreakout Watch & Consistent Return Strategy Ideas - Улправда
Recent Analysts’ Ratings Updates for Organogenesis (ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Earns “Buy” Rating from BTIG Research - Defense World
Organogenesis (NASDAQ:ORGO) Shares Gap UpTime to Buy? - MarketBeat
BTIG Research Reaffirms Buy Rating for Organogenesis (NASDAQ:ORGO) - MarketBeat
Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell - marketscreener.com
Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times
Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com Nigeria
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):